5,124 followers
New Research: Cost-effectiveness analysis of trastuzumab deruxtecan in patients with HER2-low advanced breast cancer based on DESTINY-Breast04: Background and purpose Breast cancer is a rapidly raising healthcare problem… #PublicHealth #HealthForAll https